Reinhard Franze

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Roche Diagnostics Gmbh, Hoffmann-La Roche Inc., Chugai Seiyaku Kabushiki Kaisha. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard Franze. Retrieved from https://idiyas.com/inventor/reinhard-franze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 91.7

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 92(Granted Patents)

Company Filing History:

7 out of 488

Roche Diagnostics Gmbh

patents

5 out of 5,026

Hoffmann-La Roche Inc.

patents

4 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11377678 - Method for the production of a glycosylated immunoglobulin (2022-07-05),

2. 11136610 - Method for the production of a glycosylated immunoglobulin (2021-10-05),

3. 11021728 - Method for the production of a glycosylated immunoglobulin (2021-06-01),

4. 10501769 - Method for the production of a glycosylated immunoglobulin (2019-12-10),

5. 7214532 - Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof (2007-05-08),

6. 7214514 - Identification of human cell lines for the production of human proteins by endogenous gene activation (2007-05-08),

7. 7128913 - Erythropoietin conjugates (2006-10-31),

8. 6846673 - Identification of human cell lines for the production of human proteins by endogenous gene activation (2005-01-25),

9. 6673575 - Method for preparing polypeptides with appropriate glycosilation (2004-01-06),

10. 6555373 - Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof (2003-04-29),

11. 6548296 - Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof (2003-04-15),

12. 6395484 - Identification of human cell lines for the production of human proteins by endogenous gene activation (2002-05-28),

Title: Reinhard Franze: Innovator in Immunoglobulin Production

Introduction

Reinhard Franze is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of glycosylated immunoglobulins. With a total of 12 patents to his name, Franze's work has had a considerable impact on medical and pharmaceutical advancements.

Latest Patents

One of Reinhard Franze's latest patents is a method for the production of a glycosylated immunoglobulin. This innovative method involves several key steps: first, providing a eukaryotic cell that contains a nucleic acid encoding the immunoglobulin. Next, the eukaryotic cell is cultivated in a medium where the glucose available is kept constant and limited to less than 80% of the maximum amount that could be utilized by the cells. Finally, the immunoglobulin is recovered from the culture. This method enhances the efficiency and effectiveness of immunoglobulin production.

Career Highlights

Throughout his career, Reinhard Franze has worked with prominent companies in the biotechnology sector, including Roche Diagnostics GmbH and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in immunology.

Collaborations

Reinhard has collaborated with several professionals in his field, including Michael Brandt and Ulrich Pessara. These collaborations have fostered innovation and have been instrumental in advancing their shared goals in biotechnology.

Conclusion

Reinhard Franze's contributions to the field of immunoglobulin production exemplify the importance of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.